Verition Fund Management’s Medicus Sciences Acquisition Corp. Unit MSACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-25,000
Closed -$247K 2364
2021
Q1
$247K Buy
+25,000
New +$254K ﹤0.01% 1231

Other funds holding MSACU

Verition Fund Management's MSACU Position: Q2 2021 in Review

Verition Fund Management sold out of Medicus Sciences Acquisition Corp. Unit (MSACU) in Q2 2021, closing a stake of 25,000 shares — an estimated $247K sold.

Verition Fund Management first reported a position in MSACU in Q1 2021 and held it in 1 quarter. The position peaked at $247K in Q1 2021. 1 fund tracked by Wall St. Rank holds MSACU as of Q2 2021.

  • Verition Fund Management reported no remaining Medicus Sciences Acquisition Corp. Unit position as of Q2 2021 after selling out during the quarter.
  • Verition Fund Management sold 25,000 Medicus Sciences Acquisition Corp. Unit shares in Q2 2021, an estimated $247K.
  • Verition Fund Management first reported a position in Medicus Sciences Acquisition Corp. Unit in Q1 2021 and held it in 1 quarter.
  • Verition Fund Management's Medicus Sciences Acquisition Corp. Unit position peaked at $247K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Unit as of Q2 2021.

Based on Verition Fund Management's 13F filing for Q2 2021, filed 16 Aug 2021.